Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

UNKNOWN 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 3Carcinoma, Hepatocellular 1Advanced Pancreatic Cancer 1

Interventions

Gemcitabine 4130-nm albumin-bound paclitaxel 4Albumin-Bound Paclitaxel 2paricalcitol 1irinotecan sucrosofate 1gimeracil 1fluzoparib 1cabiralizumab 1Tegafur 1S 1 (combination) 1Oxaliplatin 1Nivolumab 1Leucovorin 1Irinotecan 1IMM-101 1Fluorouracil 1ADI PEG20 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Advanced Pancreatic Cancer × gimeracil × Clear all
NCT03415802 2021-02-01

Efficacy and Safety of Nab-Paclitaxel Plus S-1 in the First-line Treatment of Advanced Pancreatic Cancer

ChineseAMS

Phase 2 Completed
32 enrolled
Gastrointestinal

Advanced Pancreatic Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡